Literature DB >> 26852957

Inhibitory gene expression of the Cav3.1 T-type calcium channel to improve neuronal injury induced by lidocaine hydrochloride.

Xianjie Wen1, Shiyuan Xu2, Qingguo Zhang3, Xiaohong Li4, Hua Liang1, Chenxiang Yang1, Hanbing Wang1, Hongzhen Liu1.   

Abstract

Cav3.1 is a low-voltage-activated (LVA) calcium channel that plays a key role in regulating intracellular calcium ion levels. In this study, we observed the effects of lidocaine hydrochloride on the pshRNA-CACNA1G-SH-SY5Y cells that silenced Cav3.1 mRNA by RNA interference, and investigated the roles of p38 MAPK in these effects. We constructed the pNC-puro-CACNA1G-SH-SY5Y cells and pshRNA-CACNA1G -SH-SY5Y cells by the RNA interference. All the cells were cultured with or without 10mM lidocaine hydrochloride for 24 h. The cell morphology, cell viability, Cav3.1 and p38 protein expression, cell apoptosis rate and intracellular calcium ion concentration were detected. We found that all cells treated with 10mM lidocaine hydrochloride for 24 h showed cellular rounding, axonal regression, and cellular floating. Compared with the cells in SH-SY5Y+Lido group and NC+Lido group, those in the RNAi+Lido group showed similar changes, but of smaller magnitude. Additionally, following lidocaine hydrochloride all cells displayed increased Cav3.1 and p38 MAPK protein, apoptosis rate, and intracellular calcium ion levels; however,these changes in the RNAi+Lido group were less pronounced than in the SH-SY5Y+Lido and NC+Lido groups. The cell viability decreased following lidocaine hydrochloride treatment, but viability of the cells in the RNAi+Lido group was higher than in the SH-SY5Y+Lido and NC+Lido groups. The results showed that Cav3.1 may be involved in neuronal injury induced by lidocaine hydrochloride and that p38 MAPK phosphorylation was reduced upon Cav3.1 gene silencing.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-(4-Amidinophenyl)−6-indolecarbamidine dihydrochloride (PubChem CID: 160166; Calcium ion (PubChem CID: 271); Cav3.1; Lidocaine hydrochloride; Lidocaine hydrochloride (PubChem CID: 6314); Propidium iodide (PubChem CID: 104981); SH-SY5Y cells; p38 MAPK

Mesh:

Substances:

Year:  2016        PMID: 26852957     DOI: 10.1016/j.ejphar.2016.02.019

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Recent advances in the development of T-type calcium channel blockers for pain intervention.

Authors:  Terrance P Snutch; Gerald W Zamponi
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

2.  CaMK II γ down regulation protects dorsal root ganglion neurons from ropivacaine hydrochloride neurotoxicity.

Authors:  Xian-Jie Wen; Xiao-Hong Li; Heng Li; Hua Liang; Chen-Xiang Yang; Han-Bing Wang
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

3.  RNA interference-based functional knockdown of the voltage-gated potassium channel Kv7.2 in dorsal root ganglion neurons after in vitro and in vivo gene transfer by adeno-associated virus vectors.

Authors:  Markus Valdor; Anke Wagner; Viola Röhrs; Johanna Berg; Henry Fechner; Wolfgang Schröder; Thomas M Tzschentke; Gregor Bahrenberg; Thomas Christoph; Jens Kurreck
Journal:  Mol Pain       Date:  2017-12-06       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.